Abstract
The expression of Stat3 (signal transducer and activator of transcription 3) in normal and neoplastic feline mammary gland tissue was assessed by immunohistochemistry in 72 cats. The samples included 3 normal nonlactating mammary tissues, 17 hyperplastic lesions (11 lobular and 6 fibroepithelial) and 52 neoplasms (5 benign and 47 malignant). For immunohistochemistry, tissue sections were incubated with anti-Stat3 monoclonal antibody and visualized with EnVision–DAB polymer. Stat3 positivity was assessed in a semiquantitative manner. Normal mammary tissue showed occasional cytoplasmic and nuclear positivity, although the number of positive cells was lower than in the hyperplastic specimens. In neoplastic tissue, high numbers of neoplastic cells with a moderate to intense cytoplasmic and nuclear positivity were observed. Selected variations in the staining pattern correlated with malignancy. Moreover, a positive association was seen between the histological grade and the Stat3 score (p < 0.0001; correlation coefficient 0.750). A linear regression model showed a positive association between mitotic count and Stat3 expression (p < 0.001). These results further support published data found in humans regarding to the relation between the expression of Stat3 and malignancy.
Similar content being viewed by others
Abbreviations
- ASC:
-
adenosquamous carcinoma
- BSA:
-
bovine serum albumin
- CA:
-
complex adenoma
- CC:
-
carcinoma cribriforme
- CSF-1:
-
colony-stimulating factor-1
- DAB:
-
3,3′-diaminobenzide tetrahydrochloride
- DC:
-
duct papilloma
- DSH:
-
domestic Short Hair
- EGFr:
-
epidermal growth factor receptor
- IFN:
-
interferon
- F:
-
female
- FEH:
-
fibroepithelial hyperplasia
- FS:
-
female spayed
- LEH:
-
lobular epithelial hyperplasia
- NMGT:
-
normal mammary gland tissue
- NR:
-
not reported
- PC:
-
Persian cat
- PBS:
-
phosphate-buffered Saline
- PDGFR:
-
platelet-derived growth factor receptor
- SA:
-
simple adenoma
- SCS:
-
simple carcinoma solid
- SCT:
-
simple carcinoma tubular
- SCTP:
-
simple carcinoma tubular papillary
- Stat3:
-
signal transducer and activator of transcription 3
- TBS:
-
Tris-buffered saline
- TNF:
-
tumour necrosis factor
- WHO:
-
World Health Organization
References
Berclaz, G., Altermatt, H.J., Rohrbach, V., Siragusa, A., Dreher, E. and Smith, P.D., 2001. EGFR dependent expression of Stat3 (but not Stat1) in breast cancer. International Journal of Cancer, 19, 1155–1160
Bowman, T., Garcia, R., Turkson, J. and Jove, R., 2000. STATs in oncogenesis. Oncogene, 19, 2474–2488
Bromberg, J., 2000. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Research, 2, 86–90
Bromberg, J., Horwath, C.M., Besser, D., Lathem, W. and Darnell, J., 1998. STAT3 activation is required for cellular transformation by v-src. Molecular Cellular Biology, 18, 2553–2558
Buettner, R., Mora, L.B. and Jove, R., 2002. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clinical Cancer Research, 8, 945–954
Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J.L., Nunez, G., Dalton, W.S. and Jove, R., 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cell. Immunity, 10, 105–115
Cattaneo, E., Magrassi, L., Se-Fraja, C., Conti, L., Di Gennaro, I. and Butti, G., 1998. Variations in the levels of the JAK-STAT and ShcA proteins in human brain tumors. Anticancer Research, 18, 2381–2387
Dias Pereira, P., Carvalheira, J. and Gärtner, F., 2004. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue—an immunohistochemical study. Veterinary Journal, 168, 180–185
Elston, C.W. and Ellis, I.O., 1996. Assessment of histological grade. In: Rosen, P.P. (ed.), Rosen's Breast Pathology, (Lippincott Raven, Philadelphia), 365–382
Garcia, R., Yu, C.L., Hudnall, A., Catlett, R., Nelson, K.L., Smithgall, T., Fujita, D.J., Ethier, S.P., and Jove, R., 1997. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth and Differentiation, 8, 1267–1276
Garcia, R., Bowman, T.L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C.A., Cox, C.E., Falcone, R., Fairclough, R., Parsons, S., Laudano, A., Gazit, A., Levitzki, A., Kraker, A. and Jove, R., 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene, 20, 2499–2513
Grandis, J.R., Drenning, S.D., Chakraborty, A., Zhou, M.Y., Zeng, O., Pitt, A.S. and Tweardy, D.J., 1998. Requirement of Stat3 but not Stat1 activation for epidermal growth factor-mediated cell growth in vitro. Journal of Clinical Investigation, 102, 1385–1392
Hirano, T., Ishiara, K. and Hibi, M., 2000. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene, 19, 2545–2556
Lund, T.C., Garcia, R., Medveczeky, M.M., Jove, R. and Medveczeky, P.G., 1997. Activation of STAT transcription factors by herpesvirus Simiri Tip-484 requires p56ck. Virology, 71, 6677–6682
Lund, T.C., Prator, P.C., Medveczeky, M.M. and Medveczeky, P.G., 1999. The Lck binding domain of herpesvirus saimiri tip-484 constitutively activates Lck and STAT3 in T cells. Journal of Virology, 73, 1689–1694
Misdorp, W., Else, R.W., Hellemén, A. and Lipscomb, T.P., 1999. Histological Classification of Mammary Tumors of the Dog and the Cat., second series, vol. VII, (Armed Forces Institute of Pathology, Washington, DC)
Murakami, Y., Nakano, S., Niho, Y., Hamasaki, N. and Izuhara, K., 1998. Constitutive activation of jak-2 and Tyk-2 in a v-src-transformed human gallbladder adenocarcinoma cell line. Journal of Cellular Physiology, 175, 220–228
Nielsen, M., Kaltoft, K., Nordahl, M., Ropke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A. and Odum, N., 1997. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tryphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proceedings of the National Academy of Sciences of the USA, 94, 6764–6769
Niu, G., Heller, R., Catlett-Falcone, R., Coppola, D., Jaroszeski, M., Dalton, W., Jove, R. and Yu, H., 1999. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Research, 59, 5059–5063
Page, C., Huang, M., Jin, X., Cho, K., Lilja, J., Reynolds, R.K. and Lin, J., 2000. Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells. International Journal of Oncology, 17, 23–28
Petterino, C., Martini, M. and Castagnaro, M., 2001. Stat3 expression in canine mammary gland tumors and mammary gland hyperplasia. European Journal of Veterinary Pathology, 7, 117–122
Sartor, C.I., Dziubinski, M.L., Yu, C.L., Jove, R. and Ethier, S.P., 1997. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Research, 57, 978–987
Seidel, H.M., Lamb, P. and Rosen, J. 2000. Pharmaceutical intervention in the JAK/STAT signalling pathway. Oncogene, 19, 2645–2656
Sun, W.H., Pabon, C., Alsayed, Y., Huang, P.P., Jandeska, S., Uddin, S., Platanias, L.C. and Rosen, S.T., 1998. Interferon-alpha resistance in cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood, 91, 570–576
Watson, C.J., 2001. Stat transcription factors in mammary gland development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia, 6, 115–127
Watson, C.J. and Miller, W.R., 1995. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. British Journal of Cancer, 71, 840–844
Weber-Nrodt, R.M., Egen, C., Wehinger, J., Ludwig, W., Gouilleaux-Gruart, V., Mertslmann, R. and Finke, J., 1996. Constitutive activation of STAT protein in primary lymphoid and myeloid leukemia cells and in Epstein–Barr virus (EBV)-related lymphoma cell lines. Blood, 88, 809–816
Zhang, Q., Novak, I., Vonderheid, E.C., Rook, A.H., Kadin, M.E., Nowell, P.C., Shaw, L.M. and Wasik, M.A., 1996. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proceedings of the National Academy of Sciences of the USA, 93, 9148–9153
Zong, C.S., Zeng, L., Jiang, Y., Sadowski, H.B. and Wang, L.H., 1998. Stat3 plays an important role in oncogenic Ros- and insulin-like growth factor I receptor induced anchorage-independent growth. Journal of Biological Chemistry, 273, 28065–28072
Zushi, S., Shinomura, Y., Kiyohara, T., Miyazaki, Y., Kondo, S., Sugimachi, M., Higashimoto, Y., Kanayama, S. and Matsuzawa, Y., 1998. STAT-3 mediates the survival the survival signal in oncogenic ras-transfected intestinal epithelial cells. International Journal of Cancer, 78, 326–330
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petterino, C., Ratto, A., Arcicasa, E. et al. Expression of Stat3 in Feline Mammary Gland Tumours and its Relation to Histological Grade. Vet Res Commun 30, 599–611 (2006). https://doi.org/10.1007/s11259-006-3335-z
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11259-006-3335-z